Is Desktop Metal, Inc. (DM) a Buy, Sell, or Hold?
NYSE : DM
Desktop Metal, Inc. — News
$4.96 USD
$0.05 (1.02%)
- Volume
- 1.28M
- Average Volume
- 1.49M
- Market Capitalization
- $165.37M
- P/E Ratio
- -0.49
- Dividend Yield
- 0.00%
- Price Target
- $5.25
- Year High
- $10.30
- Year Low
- $1.84
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.08
| Source | Headline |
|---|---|
|
Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
TORONTO, ON / ACCESS Newswire / June 30, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly owned subsidiary, QuantIP Licensing Corp. (formerly Paymetrex Payment Solutions Inc.), has completed an evaluation of 2 patents from its intellectual property portfolio using 2 artificial intelligence-driven patent analytics platforms. The evaluation focused on U.S. Patent No. accessnewswire.com - 2026-06-30 08:00:00 |
|
Datametrex Announces Rebranding of Paymetrex to QuantIP Licensing Corp.
TORONTO, ON / ACCESS Newswire / June 23, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc., has changed its name to QuantIP Licensing Corp. ("QuantIP"). The name change reflects the subsidiary's evolving strategic focus on intellectual property licensing and monetization opportunities at the intersection of payment technologies, cybersecurity, artificial intelligence, and emerging quantum encryption solutions. accessnewswire.com - 2026-06-23 08:00:00 |
|
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi gurufocus.com - 2026-05-29 07:00:00 |
|
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
TORONTO, ON / ACCESS Newswire / May 22, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly-owned subsidiary, Imagine Health Medical Clinics Ltd. ("Imagine Health" or "IH"), has officially established its Calgary Capitol Hill clinic site as a teaching facility following the onboarding of Dr. Michael Tam as a walk-in physician. accessnewswire.com - 2026-05-22 08:00:00 |
